Molly DiLullo

5PUBLICATIONS
65CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

|Dec 03, 2025
A Phase Ib Study of Sapacitabine and Olaparib in Patients with BRCA1/2-Mutated Metastatic Breast Cancer.

Filipa Lynce, Noah Graham, Bose S Kochupurakkal

|Feb 05, 2025
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer.

Shom Goel, Bojana Jovanović, Xiangying Chu

|Sep 03, 2024
A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer.

Antonio Giordano, Priya U Kumthekar, Qingchun Jin

|Aug 13, 2024
Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies.

Bojana Jovanović, Sarah E Church, Kara M Gorman

Pageof 1

Frequent Collaborators

5 joint publications

Sara M Tolaney

4 joint publications

Nabihah Tayob

3 joint publications

Elizabeth Mittendorf

3 joint publications

Nancy U Lin